[mailpoet_sector_follow]

US Broker Ratings

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 13.84% Potential Upside for Investors

Ardent Health, Inc. (ARDT), a prominent player in the healthcare sector, operates a comprehensive network of hospitals and clinics across the United States. With a market..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating the Health Information Services Sector with a 1.20% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) is an intriguing player in the healthcare sector, specializing in health information services. As a company dedicated to making prescription drug..

Teladoc Health, Inc. (TDOC) Stock Analysis: A Closer Look at Its 10% Potential Upside

Investors looking to delve into the healthcare sector’s digital transformation should consider Teladoc Health, Inc. (NYSE: TDOC), a leading player in the health information services industry...

Supernus Pharmaceuticals, Inc. (SUPN) Investor Outlook: A 31% Upside Potential Amid Strong Revenue Growth

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a prominent player in the healthcare sector, specializes in the development and commercialization of central nervous system (CNS) therapies. With its..

AdaptHealth Corp. (AHCO) Stock Analysis: Navigating a 75% Potential Upside Amidst Market Challenges

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, specifically within the medical devices industry, is drawing attention from investors with a notable 75.15%..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 24.96% Upside Potential in the Healthcare Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) stands out in the healthcare diagnostics and research industry, offering a promising opportunity for investors with a potential upside of nearly 25%...

GRAIL, Inc. (GRAL) Stock Analysis: Navigating Growth Prospects Amidst a Challenging Valuation Landscape

GRAIL, Inc. (NASDAQ: GRAL) is making waves in the healthcare sector with its innovative approach to cancer detection. As a player in the Diagnostics & Research..

Kestra Medical Technologies (KMTS) Stock Analysis: A Healthcare Innovator with 66% Revenue Growth

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is capturing investor attention with its impressive 66.2% revenue growth, positioning itself as a noteworthy player in the medical instruments..

Alphatec Holdings, Inc. (ATEC): Investor Outlook on a Potential 66% Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, stands out in the medical devices industry with a particular focus on innovative solutions..

ANI Pharmaceuticals, Inc. (ANIP)

⚠️ No article content returned.

..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Analysts Forecast a 41.83% Upside Amid Healthcare Sector Challenges

Brookdale Senior Living Inc. (NYSE: BKD), a key player in the healthcare sector, particularly within the medical care facilities industry, is capturing investor interest with a..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Unveiling a 40% Upside Potential in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is currently capturing the attention of investors with its promising outlook and significant upside..

Immunovant, Inc. (IMVT) Stock Analysis: Assessing the 21% Potential Upside with Strong Analyst Confidence

Immunovant, Inc. (NASDAQ: IMVT), a burgeoning force within the biotechnology sector, is capturing attention with a notable market cap of $8.24 billion and a unique focus..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: High ROE and 17.76% Potential Upside Highlight Growth Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), with its focus on the healthcare sector, plays a crucial role in servicing long-term care facilities (LTCFs) across the United..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a 35% Upside Potential in the Dynamic Biotech Sector

Investors in the biotechnology sector are no strangers to the allure of high-risk, high-reward opportunities, and Celldex Therapeutics, Inc. (NASDAQ: CLDX) is no exception. With a..

Haemonetics Corporation (HAE) Stock Analysis: Unveiling 11% Growth Potential Amidst Robust Healthcare Innovations

Haemonetics Corporation (NYSE: HAE), a venerable name in the healthcare sector, is making waves in the medical device industry with its innovative technologies and strategic market..

Select Medical Holdings Corp. (SEM) Stock Analysis: Navigating the Healthcare Sector with a Stable Outlook

Select Medical Holdings Corporation (NYSE: SEM) operates within the dynamic healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of..

Schrodinger, Inc. (SDGR) Stock Analysis: Is There a 9.60% Upside Potential?

Schrodinger, Inc. (NASDAQ: SDGR), a prominent player in the health information services industry, is capturing investor attention with its innovative approach to molecular discovery and drug..

Ligand Pharmaceuticals (LGND) Stock Analysis: 16% Upside Potential Amid Strong Buy Ratings

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its robust pipeline and a promising upside potential of 16.27%, according to recent analyst..

Kymera Therapeutics, Inc. (KYMR): Investor Outlook on Promising 20% Upside Potential

For individual investors eyeing the biotechnology sector, Kymera Therapeutics, Inc. (NASDAQ: KYMR) presents an intriguing opportunity. The company, headquartered in Watertown, Massachusetts, is making waves with..

Search

Funds

UK Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds